Revvity, Inc.

NYSE:RVTY

Medical - Diagnostics & Research

Healthcare
$152.43 -3.36%

-$3.40 today

Market cap
$17.02B
Beta
1.11
P/E (TTM)
45.4
EPS (TTM)
$2.15
Dividend yield
0.29%
52W Low $81.22High $118.30

Volume 1.09M

Average 1.27M

Income Statement

Follow revenue through to earnings.

Revenue

$2.86B

FY 2025 · Annual

+3.7% YoY

Operating Income

$356.63M

FY 2025 · Annual

-13.1% YoY

Net Income

$241.68M

FY 2025 · Annual

-18.3% YoY

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue3.83B3.31B2.75B2.76B2.86B
Cost of Revenue1.55B1.55B1.43B1.43B1.34B
Gross Profit2.28B1.76B1.32B1.32B1.52B
Gross Margin59.6%53.2%48.1%48.0%53.1%
Research & Development200.34M221.62M216.58M196.84M215.84M
Selling, General & Admin741.61M757.99M706.12M715.3M945.29M
Operating Expenses941.95M979.61M922.7M912.14M1.16B
Depreciation & Amortization311.44M427M431.77M427.85M405.34M
EBITDA1.62B1.18B713.56M840.25M765.8M
EBITDA Margin42.2%35.7%25.9%30.5%26.8%
Operating Income1.34B781.12M399.49M410.52M356.64M
Operating Margin35.0%23.6%14.5%14.9%12.5%
Interest Income2.24M3.59M72.13M73.19M31.1M
Interest Expense102.13M103.96M98.81M96.28M92.19M
Other Income / Expenses(136.42M)(129.29M)(216.52M)(94.39M)(88.36M)
Income Before Tax1.2B651.84M182.98M316.13M268.28M
Pre-Tax Margin31.4%19.7%6.7%11.5%9.4%
Income Tax Expense314.15M139.16M3.47M33.06M25.8M
Net Income943.16M569.18M(118.38M)295.83M241.68M
Net Margin24.6%17.2%-4.3%10.7%8.5%
EPS (Basic)8.124.51(0.95)2.412.08
EPS (Diluted)8.084.50(0.95)2.412.08
Weighted Avg Shares116.17M126.16M124.7M122.76M113.21M
Weighted Avg Shares (Diluted)116.67M126.43M124.81M122.82M113.21M

RVTY Earnings Waterfall · TTM

NYSE:RVTY · Revenue to Net Income

Key Ratios

EPS$2.10
Gross Margin52.3%
Net Margin8.1%
P/E Ratio50.5
P/S Ratio14.9

Analysis

$2.9B of revenue converted into $237.6M of net income for the selected period. Gross margin is 52.3% and net margin is 8.1%, showing how much revenue survives after costs and taxes. EPS is $2.10, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 13, 2026
10-QQuarterly reportNov 10, 2026
8-KCurrent reportNov 3, 2026
SC 13G/ASC 13G/A filingOct 7, 2026
4Statement of changes in beneficial ownershipOct 2, 2026

How much revenue does RVTY generate?

Revvity, Inc. (RVTY) reported $2.86B of revenue in fiscal 2025.

Is RVTY profitable?

Revvity, Inc. (RVTY) reported $241.68M of net income, with a net margin of 8.5%.